Rosacea Latest News Archive

Rosacea Severity Correlates With Severity of Depression Symptoms

By Dermatology Advisor Contributing Writer

Investigators utilized the PHQ-9 questionnaire and rosacea self-assessment tool to examine the relationship between the level of depression and self-assessed rosacea severity scores.

Clinical Improvement in Erythema of Rosacea With Oxymetazoline Therapy


The investigators sought to assess the reduction in persistent erythema on day 1 of therapy, using data derived from 2 pivotal trials of oxymetazoline cream 1.0% for the treatment of persistent facial erythema of rosacea.

Patch Testing Beneficial in Rosacea to Detect Contact Sensitivity


The "European standard series" contains 30 allergens and the "cosmetic series" contains 57 allergens.

Daily Oxymetazoline Cream Effective for Treatment of Persistent Erythema of Rosacea


The current analysis evaluated the proportion of patients who responded to oxymetazoline from day 1 through week 52 and the probability of response between visits.

Botulinum Toxin Mesotherapy for Refractory Rosacea


Management of rosacea can be challenging in light of the persistence of vascular symptoms that may occur following topical and systemic treatments.

Phenotype Approach to Rosacea May Help Improve Diagnosis, Classification


The current analysis identifies challenges to the application of a phenotype approach across clinical practice, epidemiologic research, interventional research, and basic science in the treatment of rosacea.

Dual-Frequency Ultrasound Promising for Treatment-Refractory Rosacea


Additional large-scale, split-face prospective studies are warranted to evaluate the independent efficacy of DFU on rosacea.

Online Forums May Harbor Harmful Information, Untested Treatments for Rosacea


Because of the lack of monitoring and the potential for misplaced trust among patients affected with rosacea, the use of forums may be fraught with detrimental outcomes.

Severe Rosacea Associated With High Out-of-Pocket Treatment Costs


A significant relationship was observed between disease severity and household income, with patients with higher levels of disease severity having lower household incomes.

Topical and Systemic Treatments for Rosacea-Associated Erythema: Weighing Your Options


With limited treatment options available for the medical management of facial erythema, telangiectases, and flushing associated with rosacea, the investigators sought to review the various topical and systemic treatments currently in use to help facilitate decision making in clinical practice.

Rosacea Has Significant Effects on Emotional, Social Well-Being


In both the ETR and PPR groups, Rosacea-Specific Quality-of-Life total and domain scores showed a negative impact associated with rosacea.

Fewer Gastrointestinal Issues in Rosacea Treated With Subantimicrobial vs Conventional Doxycycline


In a subpopulation analysis of 10,949 patients that excluded patients with documented GID in the year prior to initiating doxycycline, patients taking SD-doxycycline were significantly less likely than patients taking CD-doxycycline to experience new-onset GID.

Newly Designed Pulsed-Dye Laser Found Effective for Rosacea

Researchers investigated a pulsed-dye laser using a 15-mm diameter beam for treatment of rosacea among 20 patients.

Once-Daily Topical Treatment Effective for Rosacea-Associated Facial Erythema


Overall, the proportions of participants who attained the primary end point were significantly higher with oxymetazoline once-daily doses vs twice-daily doses.

Disease Severity, Demographics Play Important Role in Rosacea Management


Self-assessment severity scores were significantly higher in participants age <60 compared with participants age ≥60.

Topical Minocycline Foam Safe, Effective for Papulopustular Rosacea


The researchers concluded that FMX103 is a safe and effective therapy for facial papulopustular rosacea.

Clarifying Disease Characteristics of Papulopustular Rosacea


With the causative role of the Demodex mite in the development of rosacea not widely accepted, the investigators sought to explore differences in Demodex densities based on clinical characteristics historically associated with PPR and demodicosis.

Oxymetazoline Effective for Long-Term Treatment of Rosacea-Associated Facial Erythema


Throughout the 52-week study period, patients applied a pea-sized amount of the medication in a thin layer that covered the entire face, including the forehead, cheeks, nose, and chin, at the same time every morning.

Topical Oxymetazoline Effective for Reducing Rosacea-Associated Erythema


In REVEAL 1 and REVEAL 2, participants were randomly assigned to treatment with oxymetazoline or vehicle once daily for 29 days and were followed for 28 days post-treatment.

CV Risk Stratification Utilizing Validated Assessment Scales in Rosacea

Cardiovascular frequency risk was assessed using the Framingham risk score and systemic coronary risk evaluation.

Generic Rosacea Treatment Wins Tentative FDA Approval


The FDA has given tentative approval to Perrigo's ivermectin cream, which is indicated to treat inflammatory lesions of rosacea.

Increased Risk for Incident Rosacea Associated With Obesity in Women


Investigators believe this is the first longitudinal study to observe the risk for incident rosacea and obesity measurements other than body mass index only.

Sign up for Newsletters